e-Newsletter – February 2023
Our monthly e-Newsletter featuring the latest updates from Retina UK. Subscribe now to receive these updates directly to your email.
Search results
Our monthly e-Newsletter featuring the latest updates from Retina UK. Subscribe now to receive these updates directly to your email.
We have created Discover Wellbeing to help people affected by inherited sight loss to develop an awareness of emotional wellbeing and the practical skills to adapt to life’s ups and downs.
These are some of the most commonly asked questions about volunteering for our charity.
Early results from clinical testing of a gene therapy to treat X-linked retinitis pigmentosa (XLRP) have shown partial reversal of sight loss in some patients.
Back for 2023, the virtual TCS London Marathon lets you join our team close to home and get your marathon medal!
Support Retina UK and take on three of the highest, most iconic peaks in Wales within 24 hours, with The Welsh Three Peaks Challenge.
Join us for an inspiring webinar where young adults living with sight loss share their extraordinary stories and insights.
Nanoscope Therapeutics has announced positive results from their two year randomised controlled phase 2b optogenetic therapy trial for late-stage retinitis pigmentosa (RP).
Retina UK Clinical and Patient Registry Focus Groups
Dr Graham undertook research into the basic mechanisms of retinal vasculitis, inflammation of the blood vessels in the retina, and is an important cause of poor vision in patients with uveitis, inflammation of the uveal tract.